{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:55Z","timestamp":1787027815730,"version":"build-2736575974"},"reference-count":104,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation for Cellular and Molecular Medicine, Bucharest"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Squamous cell carcinoma (SCC) is a heterogeneous group of epithelial malignancies with varied morphologies and clinical behaviors. While histopathology is the diagnostic gold standard, it can be limited in distinguishing SCC from morphologic mimics. Immunohistochemistry (IHC) has therefore become a critical adjunct, enhancing diagnostic accuracy and providing prognostic insights. Objective: This narrative review aims to evaluate the diagnostic, differential, and prognostic roles of commonly used IHC markers in SCC, with particular emphasis on their utility in distinguishing SCC from histologic mimickers across different anatomical sites. Methods: One hundred and five peer-reviewed articles were analyzed for their relevance to the immunohistochemical characterization of SCC. Markers were categorized based on their diagnostic function, role in differential diagnosis, and prognostic value. Results: Key markers such as p40, p63, CK5\/6, and DSG3 consistently demonstrated high sensitivity and specificity for SCC, reinforcing their value in confirming squamous differentiation. Conversely, exclusion markers like Ber-EP4, CK7, TTF-1, S100, and SOX10 were essential in ruling out basal cell carcinoma, adenocarcinoma, and melanoma. Additionally, markers such as Ki-67, p16, and CD44 offered prognostic information regarding tumor aggressiveness, HPV status, and therapy response. These findings confirm the critical role of IHC not only in diagnosing SCC but also in resolving complex differential diagnoses. Conclusions: IHC markers serve as indispensable tools in the diagnostic workup of SCC, particularly in distinguishing it from other neoplasms with overlapping histologic features. The clear correlation between marker expression and diagnostic categories supports the systematic use of IHC to improve diagnostic precision and inform prognosis. Future integration with molecular diagnostics may further refine personalized treatment approaches in SCC.<\/jats:p>","DOI":"10.3390\/cancers17101629","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T06:17:08Z","timestamp":1747030628000},"page":"1629","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunohistochemistry for Skin Cancers: A Comprehensive Approach to the Diagnosis of Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"17","author":[{"given":"Vlad-Mihai","family":"Voiculescu","sequence":"first","affiliation":[{"name":"Department of Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Elias Emergency University Hospital, 011461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1169-0049","authenticated-orcid":false,"given":"Radu-Marian","family":"Marinescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9902-725X","authenticated-orcid":false,"given":"Sorin","family":"Dutulescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Pathology Department, \u201cMatei Bals\u201d National Institute for Infectious Diseases, 021105 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florica","family":"St\u0103niceanu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Pathology Department, \u201cMatei Bals\u201d National Institute for Infectious Diseases, 021105 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.4103\/jcrt.jcrt_43_21","article-title":"Association of P16, Ki-67, and CD44 expression in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of the cervix","volume":"19","author":"Mehdi","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"ref_2","first-page":"33","article-title":"Evaluation of CD44 and TGF-B Expression in Oral Carcinogenesis","volume":"22","author":"Ghazi","year":"2021","journal-title":"J. Dent."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105680","DOI":"10.1016\/j.oraloncology.2021.105680","article-title":"Spindle cell carcinoma of the lip: An immunohistochemical study of a challenging case","volume":"125","author":"Scarini","year":"2022","journal-title":"Oral Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.25259\/Cytojournal_78_2019","article-title":"Greater specificity of p40 compared with p63 in distinguishing squamous cell carcinoma from adenocarcinoma in effusion cellblocks","volume":"17","author":"Kim","year":"2020","journal-title":"CytoJournal"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DAD.0000000000002504","article-title":"Perianal Cutaneous Spindle Cell Squamous Cell Carcinoma with Myxoid Stroma: Case Report and Literature Review","volume":"45","author":"Zhurauliou","year":"2023","journal-title":"Am. J. Dermatopathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0714.2009.00843.x","article-title":"Clinicopathological and immunohistochemical features of oral spindle cell carcinoma","volume":"39","author":"Romanach","year":"2010","journal-title":"J. Oral Pathol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/etm.2022.11308","article-title":"Role of immunohistochemistry in the diagnosis and staging of cutaneous squamous-cell carcinomas (Review)","volume":"23","author":"Gheorghe","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12015-022-10486-x","article-title":"Loss of Epidermal Homeostasis Underlies the Development of Squamous Cell Carcinoma","volume":"19","author":"Jaiswal","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"153733","DOI":"10.1016\/j.prp.2021.153733","article-title":"Immunohistochemical comparison of p63 and p40 in head and neck Spindle Cell Carcinoma","volume":"229","author":"Sahu","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153909","DOI":"10.1016\/j.prp.2022.153909","article-title":"Clear cell squamous cell carcinoma of the tongue exhibits characteristics as an undifferentiated squamous cell carcinoma","volume":"235","author":"Hasegawa","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25050","DOI":"10.18632\/oncotarget.7732","article-title":"Squamous cell carcinomas of the lung and of the head and neck: New insights on molecular characterization","volume":"7","author":"Polo","year":"2016","journal-title":"Oncotarget"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.2011.173","article-title":"P40 (\u0394Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma","volume":"25","author":"Bishop","year":"2012","journal-title":"Mod.Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2220940","DOI":"10.1155\/2022\/2220940","article-title":"Characterization of Desmoglein 3 (DSG3) as a Sensitive and Specific Marker for Esophageal Squamous Cell Carcinoma","volume":"2022","author":"Chi","year":"2022","journal-title":"Gastroenterol. Res.Pract."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102300","DOI":"10.1016\/j.ajoc.2025.102300","article-title":"Basal cell carcinoma and squamous cell carcinoma of the conjunctiva in a single lesion","volume":"38","author":"Trudrung","year":"2025","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3892\/ol.2023.13948","article-title":"S100 proteins in head and neck squamous cell carcinoma (Review)","volume":"26","author":"Hu","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_16","unstructured":"(2025, April 20). P53, p16 and Ki67 Immunoexpression in Cutaneous Squamous Cell Carcinoma and Its Precursor Lesions\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/27833960\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.47162\/RJME.65.1.03","article-title":"Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma","volume":"65","author":"Stoica","year":"2024","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/1742-6413.94570","article-title":"Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens","volume":"9","author":"Sethi","year":"2012","journal-title":"Cytojournal"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cyt.12741","article-title":"The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung","volume":"30","author":"Schubert","year":"2019","journal-title":"Cytopathology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.humpath.2014.01.005","article-title":"The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer","volume":"45","author":"Ao","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.5858\/arpa.2013-0342-OA","article-title":"An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers","volume":"138","author":"Tacha","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_22","first-page":"674","article-title":"Variations of P40 and P63 Immunostains in Different Grades of Esophageal Squamous Cell Carcinoma: A Potential Diagnostic Pitfall","volume":"29","author":"Chi","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/cup.12388","article-title":"p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma","volume":"41","author":"Alomari","year":"2014","journal-title":"J. Cutan. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PAS.0000000000000119","article-title":"Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes","volume":"38","author":"Bishop","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cup.12387","article-title":"Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma","volume":"41","author":"Chen","year":"2014","journal-title":"J. Cutan. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13193-021-01418-1","article-title":"Spindle Cell Squamous Cell Carcinoma of Head and Neck Region: A Clinicopathological and Immunohistochemical Study","volume":"12","author":"Neha","year":"2021","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jasc.2015.07.002","article-title":"Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations","volume":"5","author":"Lilo","year":"2016","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Smirnov, A., Anemona, L., Novelli, F., Piro, C.M., Annicchiarico-Petruzzelli, M., Melino, G., and Candi, E. (2019). p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225781"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.tripleo.2009.07.011","article-title":"Basaloid squamous cell carcinoma of the mandible: Report of two cases","volume":"108","author":"Hirai","year":"2009","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PAS.0b013e3182036d05","article-title":"Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5\/6","volume":"35","author":"Mukhopadhyay","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcms.2021.11.015","article-title":"Desmoglein-3 overexpression in oral squamous cell carcinoma is associated with metastasis formation and early recurrence: An immunohistochemical study","volume":"50","author":"Troeltzsch","year":"2022","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00428-007-0485-5","article-title":"Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: Correlation with lymph node metastasis and cell proliferation","volume":"451","author":"Wang","year":"2007","journal-title":"Virchows Arch."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.yexcr.2018.06.037","article-title":"Desmoglein 3\u2014Influence on oral carcinoma cell migration and invasion","volume":"370","author":"Apu","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2353\/ajpath.2009.080778","article-title":"The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung","volume":"174","author":"Kosari","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_35","first-page":"350","article-title":"Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes","volume":"20","author":"Agackiran","year":"2012","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"154200","DOI":"10.1016\/j.prp.2022.154200","article-title":"Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors","volume":"240","author":"Viehweger","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.acthis.2014.01.010","article-title":"Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma","volume":"116","author":"Fang","year":"2014","journal-title":"Acta Histochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1074\/mcp.M116.064451","article-title":"Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth","volume":"16","author":"Kim","year":"2017","journal-title":"Mol. Cell. Proteom."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/modpathol.3800329","article-title":"p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma","volume":"18","author":"Emanuel","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_40","first-page":"155","article-title":"A diagnostic pitfall; Small cell carcinoma-like features in basaloid squamous cell carcinoma of the esophagus","volume":"38","author":"Ishida","year":"2023","journal-title":"Histol. Histopathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3892\/ol.2014.2318","article-title":"Basaloid squamous cell carcinoma of the maxillary gingiva: A case report and review of the literature","volume":"8","author":"Xie","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bjorl.2020.07.010","article-title":"Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck","volume":"88","author":"Alaeddini","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2018.02.013","article-title":"S100 proteins in oral squamous cell carcinoma","volume":"480","author":"Raffat","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000074423","article-title":"Tumor marker workshops","volume":"24","author":"Rye","year":"2003","journal-title":"Tumour Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/cup.13468","article-title":"SOX-10 staining in dermal scars","volume":"46","author":"Behrens","year":"2019","journal-title":"J. Cutan. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/cup.12135","article-title":"Expression of CK7, Cam 5.2 and Ber-Ep4 in cutaneous squamous cell carcinoma","volume":"40","author":"Clarke","year":"2013","journal-title":"J. Cutan. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.2147\/CMAR.S250867","article-title":"SOX10\u2014A Novel Marker for the Differential Diagnosis of Breast Metaplastic Squamous Cell Carcinoma","volume":"12","author":"Qi","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1524-4725.2000.99287.x","article-title":"Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma","volume":"26","author":"Tope","year":"2000","journal-title":"Dermatol. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ouh, Y.-T., Kim, H.Y., Yi, K.W., Lee, N.-W., Kim, H.-J., and Min, K.-J. (2024). Enhancing Cervical Cancer Screening: Review of p16\/Ki-67 Dual Staining as a Promising Triage Strategy. Diagnostics, 14.","DOI":"10.20944\/preprints202401.0786.v1"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.31557\/APJCP.2022.23.10.3405","article-title":"P16\/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women","volume":"23","author":"Aromseree","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1940-6207.CAPR-19-0144","article-title":"Performance of HPV genotyping combined with p16\/Ki-67 in detection of cervical precancer and cancer among HPV-positive Chinese women","volume":"13","author":"Jiang","year":"2020","journal-title":"Cancer Prev. Res."},{"key":"ref_53","unstructured":"(2025, April 20). Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/27509952\/."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13224-020-01380-y","article-title":"Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear","volume":"71","author":"Gothwal","year":"2021","journal-title":"J. Obstet. Gynaecol. India"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.21037\/tcr.2019.12.08","article-title":"A comparative study of osteopontin expression, Ki67 index and prognosis in squamous cell carcinoma and cysts of the oral cavity","volume":"9","author":"Nahajowski","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/hed.25331","article-title":"Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma","volume":"40","author":"Lee","year":"2018","journal-title":"Head Neck"},{"key":"ref_57","unstructured":"(2025, March 28). Evaluation of CD24 and CD44 as Cancer Stem Cell Markers in Squamous Cell Carcinoma and Epithelial Dysplasia of the Oral Cavity by q- RT-PCR\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/32774798\/."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s00432-022-04222-8","article-title":"Prognostic utility of SOX2, STAT3, and CD44high\/CD24low expression in penile cancer","volume":"149","author":"Torres","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1111\/cas.14182","article-title":"Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma","volume":"110","author":"Okazaki","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"81571","DOI":"10.18632\/oncotarget.13147","article-title":"Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3\u2032-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma","volume":"7","author":"Fujii","year":"2016","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e33304","DOI":"10.7554\/eLife.33304","article-title":"YAP drives cutaneous squamous cell carcinoma formation and progression","volume":"7","author":"Elbediwy","year":"2018","journal-title":"eLife"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100411","DOI":"10.1016\/j.xcrm.2021.100411","article-title":"Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma","volume":"2","author":"Liu","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5114\/pjp.2018.75335","article-title":"Clinical efficacy of p16\/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer","volume":"69","author":"Celewicz","year":"2018","journal-title":"Pol. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/ijpm.ijpm_656_21","article-title":"Evaluation of variable p16 immunostaining patterns, Ki-67 indices and HPV status in cervical SILs and squamous cell carcinomas: An institutional experience","volume":"66","author":"Singh","year":"2023","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.soc.2016.07.013","article-title":"Pathology of Anal Cancer","volume":"26","author":"Hoff","year":"2017","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0463.2008.00932.x","article-title":"If it\u2019s not CK5\/6 positive, TTF-1 negative it\u2019s not a squamous cell carcinoma of lung","volume":"116","author":"Downey","year":"2008","journal-title":"APMIS"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.prp.2014.06.021","article-title":"Analysis of clinical characteristics and differential diagnosis of the lung biopsy specimens in 99 adenocarcinoma cases and 111 squamous cell carcinoma cases: Utility of an immunohistochemical panel containing CK5\/6, CK34\u03b2E12, p63, CK7 and TTF-1","volume":"210","author":"Xu","year":"2014","journal-title":"Pathol. Res. Pract."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.onc.1209802","article-title":"DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis","volume":"26","author":"Chen","year":"2007","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1600-0560.2010.01562.x","article-title":"CK7 expression in primary cutaneous squamous cell carcinoma","volume":"37","author":"Pulitzer","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00405-021-06894-3","article-title":"Cytokeratin 7 and 19 expression in oropharyngeal and oral squamous cell carcinoma","volume":"279","author":"Woods","year":"2022","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12105-018-0990-7","article-title":"SOX10 Immunoexpression in Basaloid Squamous Cell Carcinomas: A Diagnostic Pitfall for Ruling out Salivary Differentiation","volume":"13","author":"Rooper","year":"2019","journal-title":"Head Neck Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1471-0528.13071","article-title":"HPV-negative carcinoma of the uterine cervix: A distinct type of cervical cancer with poor prognosis","volume":"122","author":"Soveral","year":"2015","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41379-019-0249-1","article-title":"HPV-negative tumors of the uterine cervix","volume":"32","author":"Marimon","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/his.14824","article-title":"WHO 2022 classification of penile and scrotal cancers: Updates and evolution","volume":"82","author":"Menon","year":"2023","journal-title":"Histopathology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12029-022-00850-y","article-title":"The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: A Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT","volume":"54","author":"Rimini","year":"2023","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hed.25158","article-title":"Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma","volume":"40","author":"Rodrigues","year":"2018","journal-title":"Head Neck"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.7314\/APJCP.2014.15.16.6761","article-title":"Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: A meta-analysis","volume":"15","author":"Zhao","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Xu, R., Wong, C.H., Chan, K.S., and Chiang, C.L. (2024). PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: A systematic review and meta-analysis of prospective trials. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1386381"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00262-024-03635-3","article-title":"Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells","volume":"73","author":"Rajasekaran","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4103\/jcrt.JCRT_1606_20","article-title":"Prognostic role of programmed cell death ligand-1 expression in head and neck cancer treated with programmed cell death protein-1\/programmed cell death ligand-1 inhibitors: A meta-analysis based on clinical trials","volume":"17","author":"Huang","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1470-2045(21)00136-4","article-title":"Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: An open-label, multi-arm, non-randomised, multicentre, phase 2 trial","volume":"22","author":"Sacco","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.celrep.2019.07.027","article-title":"p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas","volume":"28","author":"Hsieh","year":"2019","journal-title":"Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"0300060519893867","DOI":"10.1177\/0300060519893867","article-title":"Use of dual-marker staining to differentiate between lung squamous cell carcinoma and adenocarcinoma","volume":"48","author":"Guo","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2016.02.027","article-title":"Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases","volume":"54","author":"Sharma","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cncy.21707","article-title":"Napsin A\/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens","volume":"124","author":"Nishino","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345245","article-title":"p40: A p63 isoform useful for lung cancer diagnosis\u2014a review of the physiological and pathological role of p63","volume":"57","author":"Nobre","year":"2013","journal-title":"Acta Cytol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Balcere, A., Sperga, M., \u010c\u0113ma, I., Lauskis, G., Zolovs, M., Kupfere, M.R., and Kr\u016bmi\u0146a, A. (2023). Expression of p53, p63, p16, Ki67, Cyclin D, Bcl-2, and CD31 Markers in Actinic Keratosis, In Situ Squamous Cell Carcinoma and Normal Sun-Exposed Skin of Elderly Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12237291"},{"key":"ref_88","first-page":"253","article-title":"Squamous cell carcinoma arising in association with verruca vulgares and HPV-2: A clinicopathologic study with p16 and p53 immunohistochemical studies and human papillomavirus in situ hybridization studies","volume":"22","author":"Ruhoy","year":"2014","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/cyt.13310","article-title":"Dual Sec62\/Ki67 immunocytochemistry of liquid-based cytological preparations represents a highly valid biomarker for non-invasive detection of head and neck squamous cell carcinomas","volume":"35","author":"Speicher","year":"2024","journal-title":"Cytopathology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/j.lpm.2014.08.008","article-title":"Cutaneous HPV and skin cancer","volume":"43","author":"Accardi","year":"2014","journal-title":"Presse Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/jcp.2007.047720","article-title":"Technical pitfalls potentially affecting diagnoses in immunohistochemistry","volume":"61","author":"Bussolati","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"ref_92","first-page":"31","article-title":"Influence of fixation, antibody clones, and threshold value on Ki-67 labeling of breast cancer tissue","volume":"113","author":"Masood","year":"2000","journal-title":"Histochem. Cell Biol."},{"key":"ref_93","unstructured":"ASCO\/CAP Guidelines (2020). Recommendations for Optimal Fixation and Handling of Tissue Specimens for Pathology. Arch. Pathol. Lab. Med., 144, 426\u2013437."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5858\/132.12.1929","article-title":"Tissue Handling and Specimen Preparation in Surgical Pathology: Issues Concerning the Recovery of Nucleic Acids from Formalin-Fixed, Paraffin-Embedded Tissue","volume":"132","author":"Hewitt","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_95","first-page":"831","article-title":"Quality assurance and standardization in immunohistochemistry: A requirement for increased clinical use","volume":"49","author":"Taylor","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"ref_96","first-page":"263","article-title":"Quantitation in immunohistology: Fact or fiction?","volume":"112","author":"Leong","year":"2004","journal-title":"APMIS"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.5858\/arpa.2014-0083-RA","article-title":"Overview of automated immunohistochemistry","volume":"138","author":"Prichard","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_98","unstructured":"(2025, March 23). UK NEQAS ICC & ISH Annual Reports. Available online: https:\/\/ukneqas.org.uk."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.5858\/arpa.2013-0610-CP","article-title":"Principles of Analytic Validation of Immunohistochemical Assay","volume":"138","author":"Fitzgibbons","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.media.2014.11.010","article-title":"Assessment of algorithms for mitosis detection in breast cancer histopathology images","volume":"20","author":"Veta","year":"2015","journal-title":"Med. Image Anal."},{"key":"ref_101","first-page":"32","article-title":"Next-generation diagnostic pathology: Use of digital pathology and artificial intelligence tools to augment a pathologist\u2019s diagnostic workflow","volume":"10","author":"Parwani","year":"2019","journal-title":"J. Pathol. Inform."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Canini, V., Eccher, A., D\u2019amati, G., Fusco, N., Maffini, F., Lepanto, D., Martini, M., Cazzaniga, G., Paliogiannis, P., and Lobrano, R. (2024). Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051240"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Moratin, J., Mock, A., Obradovic, S., Metzger, K., Flechtenmacher, C., Zaoui, K., Fr\u00f6hling, S., J\u00e4ger, D., Krauss, J., and Hoffmann, J. (2021). Digital Pathology Scoring of Immunohistochemical Staining Reliably Identifies Prognostic Markers and Anatomical Associations in a Large Cohort of Oral Cancers. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.712944"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41377-023-01104-7","article-title":"Deep learning-enabled virtual histological staining of biological samples","volume":"12","author":"Bai","year":"2023","journal-title":"Light Sci. Appl."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1629\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:31:08Z","timestamp":1760031068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":104,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["cancers17101629"],"URL":"https:\/\/doi.org\/10.3390\/cancers17101629","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}